0001213900-24-009722.txt : 20240202 0001213900-24-009722.hdr.sgml : 20240202 20240202170359 ACCESSION NUMBER: 0001213900-24-009722 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 EFFECTIVENESS DATE: 20240202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-504322 FILM NUMBER: 24592552 BUSINESS ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 D 1 primary_doc.xml X0708 D LIVE 0001860657 Allarity Therapeutics, Inc. 24 SCHOOL ST., 2ND FLOOR BOSTON MA MASSACHUSETTS 02108 401-426-4664 DELAWARE None None Corporation true 2021 Thomas Jensen 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Executive Officer Director Joan Brown 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Executive Officer Gerald McLaughlin 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Laura Benjamin 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Joseph Vazzano 24 School Street, 2nd Floor Boston MA MASSACHUSETTS 02108 Director Biotechnology Decline to Disclose 06b false 2024-01-18 false true true Senior Convertible Promissory Notes false 0 1400000 400000 1000000 $400,000 represents the subscription amount of senior promissory note issued and sold to 1 accredited institutional investor, pursuant to a securities purchase agreement, dated January 18, 2024. false 1 0 0 0 false Allarity Therapeutics, Inc. /s/ Thomas Jensen Thomas Jensen Chief Executive Officer 2024-02-02